APOE and Alzheimer disease: Since protection against ferroptosis did not differ between APOE isoforms in vitro, other features of APOE4 carriers, such as a low abundance of APOE protein expression and/or higher levels of PUFAs, could mediate the higher risk of APOE4 allele carriers for AD (Belaidi et al. 2022).